SMO Turkey

SMO Turkey is authorized to perform storage, distribution, import/export, return from sites, destruction and additional labelling services of Investigational Medicinal Products including controlled drugs.

Country information

With its unique geographical location creating a physical, cultural and commercial bridge between East and West, Turkey has been displaying an exponential growth in the number of sponsored clinical trials.

Turkey — home to an 80 million-strong population, a substantial pharmaceuticals market and a universal healthcare system that is the envy of its’ neighbors — stands as a prospective healthcare and life science investment destination in its region. With a high number of potential patients — who are largely treatment-naïve — a practical regulatory process and competitive cost structure, Turkey is fast becoming the ideal location for global clinical trials. Sponsors should explore its’ full offerings, ideally teaming up with a local partner who can overcome the country’s research obstacles.

With a high number of potential patients — who are largely treatment-naïve — a practical regulatory process and competitive cost  structure, Turkey is fast becoming the ideal location for global clinical trials. Sponsors should explore its’ full offerings, ideally teaming up with a local
partner who can overcome the country’s research obstacles.